Bill Taranto is the founder, President and General Partner of the Merck Global Health Innovation Fund (MGHIF), LLC and VP Merck Global Health Innovation Group. The Merck Global Health Innovation Fund was established in late 2010 as a strategic response to the challenges surrounding Merck's core business of discovering, developing, and marketing innovative drugs and vaccines. The $500 million evergreen fund is focused on identifying opportunities that are adjacent to Merck’s core business of pharmaceuticals and vaccines. It is one of the largest and most successful corporate venture firms specializin...read more